Pardes Biosciences, Inc. (PRDS)

$1.66

0.00 (0.00%)
Rating:
Recommendation:
-
Symbol PRDS
Price $1.66
Beta 0.000
Volume Avg. 0.14M
Market Cap 103.453M
Shares () -
52 Week Range 1.63-17.76
1y Target Est -
DCF Unlevered PRDS DCF ->
DCF Levered PRDS LDCF ->
ROE -11.66% Sell
ROA -9.17% Neutral
Operating Margin -
Debt / Equity 5.04% Neutral
P/E -
P/B 0.43 Neutral
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest PRDS news


Healthcare
Biotechnology
NASDAQ Global Market

Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California.